NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

enVVeno Medical Corporation (NVNO) Stock Analysis

enVVeno Medical Corporation (NVNO) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

NVNO

$11.44

+$0.34 (+3.05%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare NVNO with… →

NVNO Key Statistics

As of Sep 4, 2026
Trading
Open
$11.05
Previous Close
$11.10
Day's Range
11.05–11.44
52-Week Range
8.67–35.70
Volume
2.10K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.07
Valuation
Market Cap
$7.95M
P/E Ratio
unprofitable
EPS (ttm)Profit attributable to each share over the last twelve months.
−24.97
Financials (FY)
Revenue (FY)
$0.00
Net Income (FY)
−$19.47M
Profit marginThe share of revenue left as profit after all costs and taxes.
0.00%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
694.83K
1-Year Return
−58.58%
Dividend and dates
Avg Volume
16.62K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

NVNO Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+1.82%
2025−89.37%
2024−41.25%
2023+0.78%
2022−22.61%
2021−23.82%
2020−37.09%
2019−62.71%
2018 (partial year)−71.85%

As of September 4, 2026.

NVNO Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$0.00−$19.47M—
2024$0.00−$21.82M—
2023$0.00−$23.52M—
2022$0.00−$24.67M—
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$0.00—−$20.90M−$19.47M—
2024$0.00—−$23.83M−$21.82M—
2023$0.00—−$25.24M−$23.52M—
2022$0.00—−$24.93M−$24.67M—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

NVNO Valuation vs Medical Devices Median

Median of 151 stocks
MetricNVNOMedical Devices medianvs median
Profit margin0.00%−1.69%1.7 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values enVVeno Medical Corporation (NVNO) at $7.95M. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 33.

NVNO last closed at $11.44 on September 4, 2026. That is +$0.34 (+3.05%) against the previous close. Over the past 52 weeks the price has ranged from $8.67 to $35.70. The latest close sits 31.94% above that 52-week low.

Financial Health

In fiscal 2025, enVVeno Medical Corporation reported revenue of $0.00. The same year closed with a net loss of $19.47M. Profit margin runs at 0%. That is 1.7 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are −24.97.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $0.00 in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published.

The trailing one-year price return is −58.58%. Across 5 years the annualized return works out at −47.37%. Beta against the wider market is reported at 1.07. Annualized volatility over the trailing 8 years is 93.08%.

Growth & Income

No dividend is on file for NVNO.

The strongest complete calendar year on file is 2023 at +0.78%; the weakest is 2025 at −89.37%. Of the 7 complete calendar years on file, 1 finished higher. 2026 is still running; the price is +1.82% year to date.

Peer Comparison

enVVeno Medical Corporation (NVNO) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
enVVeno Medical Corporation NVNO $7.95M —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. enVVeno Medical Corporation has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About enVVeno Medical Corporation

enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Visit website →